AVIR logo

Atea Pharmaceuticals, Inc. (AVIR)

Profile

Full Name

Atea Pharmaceuticals, Inc.

Ticker

NASDAQ: AVIR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 30, 2020

Indexes

Not included

Website

http://ateapharma.com

Employees

56

Key Details

Price

$3.90(+4.28%)

Market cap

$333.76M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.00(-22.70% YoY)

PE ratio

-

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.90
    AVIR price is $3.90

    30-Day Relative Volume

    1.06
    AVIR 30-day relative volume is 1.06

    Price Performance

    Price Most recent change

    +4.28%
    AVIR price was up +4.28% on Jul 25, 2025

    Price YTD change

    +16.42%
    AVIR price is up +16.42% since January 1st

    Price 1-year change

    0%
    AVIR price has remained unchanged year-on-year

    Price 3-year change

    -52.38%
    AVIR price is down -52.38% over the past 3 years

    Price Range

    Price All-time high

    $94.17
    AVIR price is currently -95.86% below its historical high of $94.17

    Price 3-year low

    $2.46
    AVIR price is currently +58.86% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $333.76M
    AVIR market capitalization is $333.76 million

    Market cap 3-year change

    -51.05%
    AVIR market capitalization is down -51.05% over the past 3 years

    Market cap All-time high

    $7.29B
    AVIR market capitalization is currently -95.42% below its historical high of $7.29 billion

    Market cap sector rank

    59.69%
    AVIR market capitalization is higher than 59.69% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.37%
    AVIR shares outstanding is up +1.37% year-on-year

    Shares Outstanding 3-Year Change

    +2.79%
    AVIR shares outstanding is up +2.79% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.78
    AVIR beta is 0.78

    200-day SMA

    $3.18
    AVIR price is currently +22.55% above its 200-day simple moving average

    50-day SMA

    $3.29
    AVIR price is currently +18.50% above its 50-day simple moving average

    RSI

    67.75
    AVIR 14-day relative strength index is 67.75

    Volume

    1.06
    AVIR 30-day relative volume is 1.06

    ATR

    $0.16
    AVIR average true range is $0.16

    10-day Historical Volatility

    57.51%
    AVIR 10-day historical volatility is 57.51%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    AVIR annual revenue value is unknown

    Revenue Analysts estimate

    -
    AVIR annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    AVIR annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    AVIR annual revenue is unknown

    EPS

    EPS

    -$2.00
    AVIR annual earnings per share is -$2.00

    EPS Analysts estimate

    -$2.02
    AVIR annual earnings per share is currently -0.96% lower than the consensus analysts' forecast

    EPS 1-year change

    -22.7%
    AVIR annual earnings per share is down -22.7% year-on-year

    EPS Sector rank

    39.34%
    AVIR annual earnings per share is higher than 39.34% of companies in Healthcare sector

    Profit

    Gross profit

    -
    AVIR annual gross profit value is unknown

    Gross margin

    -
    AVIR annual gross profit margin value is unknown

    Operating profit

    -$192.95M
    AVIR annual operating income is -$192.95 million

    Operating margin

    -
    AVIR annual operating profit margin value is unknown

    Net income

    -$168.38M
    AVIR annual net profit is -$168.38 million

    Net margin

    -
    AVIR annual net profit margin value is unknown

    Expenses

    Total expenses

    $192.95M
    AVIR annual total expenses is $192.95 million

    Operating expenses

    $192.95M
    AVIR annual total operating expenses is $192.95 million

    Cost of goods sold

    -
    AVIR annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $48.85M
    AVIR annual SGA is $48.85 million

    Depreciation and amortization

    $416.00K
    AVIR annual depreciation & amortization is $416.00 thousand

    Interest expense

    -
    AVIR annual interest expense value is unknown

    Income tax

    $925.00K
    AVIR annual income tax is $925.00 thousand

    EBIT & EBITDA

    EBIT

    -$192.95M
    AVIR annual earnings before interest & taxes is -$192.95 million

    EBITDA

    -$192.53M
    AVIR annual EBITDA is -$192.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $464.67M
    AVIR annual total assets is $464.67 million

    Non current assets

    $2.31M
    AVIR annual long term assets is $2.31 million

    Current assets

    $462.36M
    AVIR annual total current assets is $462.36 million

    Cash and cash equivalents

    $64.70M
    AVIR annual cash & cash equivalents is $64.70 million

    Accounts receivable

    -
    AVIR annual accounts receivable value is unknown

    Inventory

    -
    AVIR annual inventory value is unknown

    Liabilities

    Total liabilities

    $25.80M
    AVIR annual total liabilities is $25.80 million

    Long term liabilities

    $7.20M
    AVIR annual total long term liabilities is $7.20 million

    Current liabilities

    $18.60M
    AVIR annual total current liabilities is $18.60 million

    Accounts payable

    $4.46M
    AVIR annual accounts payable is $4.46 million

    Debt

    Total debt

    $1.64M
    AVIR annual total debt is $1.64 million

    Total debt 1-year change

    -31.64%
    AVIR annual total debt is down -31.64% year-on-year

    Long term debt

    $842.00K
    AVIR annual long term debt is $842.00 thousand

    Short term debt

    $800.00K
    AVIR annual short term debt is $800.00 thousand

    Equity & Capital

    Shareholders equity

    $438.87M
    AVIR annual stockholders equity is $438.87 million

    Book value

    $438.87M
    AVIR annual book value is $438.87 million

    Retained earnings

    -$364.22M
    AVIR annual retained earnings is -$364.22 million

    Working capital

    $443.75M
    AVIR annual working capital is $443.75 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$135.50M
    AVIR annual cash flow from operations is -$135.50 million

    Cash from operations 1-year change

    -58.67%
    AVIR annual cash flow from operations is down -58.67% year-on-year

    Cash from investing

    $56.10M
    AVIR annual cash flow from investing activities is $56.10 million

    Cash from investing 1-year change

    +39.21%
    AVIR annual cash flow from investing activities is up +39.21% year-on-year

    Cash from financing

    $267.00K
    AVIR annual cash flow from financing activities is $267.00 thousand

    Cash from financing 1-year change

    +3.89%
    AVIR annual cash flow from financing activities is up +3.89% year-on-year

    CAPEX

    CAPEX

    -
    AVIR annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    AVIR annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$135.50M
    AVIR annual free cash flow is -$135.50 million

    Free cash flow 1-year change

    -58.67%
    AVIR annual free cash flow is down -58.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    AVIR annual gross profit margin value is unknown

    Operating margin

    -
    AVIR annual operating profit margin value is unknown

    Net margin

    -
    AVIR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -36.24%
    AVIR annual return on assets is -36.24%

    ROE

    -38.37%
    AVIR annual return on equity is -38.37%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AVIR price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AVIR price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.81
    AVIR price to book ratio is 0.81

    PB ratio Sector rank

    33.25%
    AVIR price to book ratio is higher than 33.25% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    AVIR price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AVIR price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $215.81M
    AVIR enterprise value is $215.81 million

    Enterprise value Sector rank

    54.38%
    AVIR enterprise value is higher than 54.38% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.33
    AVIR EV/EBITDA is -1.33

    EV/EBITDA Sector rank

    46.21%
    AVIR EV/EBITDA is higher than 46.21% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    24.85
    AVIR annual current ratio is 24.85

    Quick ratio

    -
    AVIR annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    AVIR annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    AVIR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    AVIR piotroski f-score value is unknown

    Altman Z-Score

    -
    AVIR altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Apr 11, 25 Morgan Stanley
    Equal-Weight
    Aug 13, 24 Morgan Stanley
    Equal-Weight
    Aug 10, 23 JP Morgan
    Underweight
    Mar 16, 23 JP Morgan
    Neutral
    Jan 27, 23 SVB Leerink
    Market Perform
    Jan 24, 23 Morgan Stanley
    Underweight
    Aug 15, 22 Morgan Stanley
    Underweight
    Mar 2, 22 JP Morgan
    Neutral
    Mar 1, 22 SVB Leerink
    Market Perform
    Feb 16, 22 SVB Leerink
    Market Perform

    Institutional Ownership

    Screeners with AVIR included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks recommended to hold
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Atea Pharmaceuticals, Inc.?
    • Does Atea Pharmaceuticals, Inc. pay dividends?
    • What sector is Atea Pharmaceuticals, Inc. in?
    • What industry is Atea Pharmaceuticals, Inc. in?
    • What country is Atea Pharmaceuticals, Inc. based in?
    • When did Atea Pharmaceuticals, Inc. go public?
    • Is Atea Pharmaceuticals, Inc. in the S&P 500?
    • Is Atea Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Atea Pharmaceuticals, Inc. in the Dow Jones?
    • When was Atea Pharmaceuticals, Inc.'s last earnings report?
    • When does Atea Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Atea Pharmaceuticals, Inc.?

    The ticker symbol for Atea Pharmaceuticals, Inc. is NASDAQ:AVIR

    Does Atea Pharmaceuticals, Inc. pay dividends?

    No, Atea Pharmaceuticals, Inc. does not pay dividends

    What sector is Atea Pharmaceuticals, Inc. in?

    Atea Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Atea Pharmaceuticals, Inc. in?

    Atea Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Atea Pharmaceuticals, Inc. based in?

    Atea Pharmaceuticals, Inc. is headquartered in United States

    When did Atea Pharmaceuticals, Inc. go public?

    Atea Pharmaceuticals, Inc.'s initial public offering (IPO) was on October 30, 2020

    Is Atea Pharmaceuticals, Inc. in the S&P 500?

    No, Atea Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Atea Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Atea Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Atea Pharmaceuticals, Inc. in the Dow Jones?

    No, Atea Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Atea Pharmaceuticals, Inc.'s last earnings report?

    Atea Pharmaceuticals, Inc.'s most recent earnings report was on May 12, 2025

    When does Atea Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Atea Pharmaceuticals, Inc. is August 7, 2025
    On this page